Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-555P is a human pseudogene related to U6 small nuclear RNA, a component of the spliceosomal complex involved in pre-mRNA splicing[1][3]. While U6 small nuclear RNA itself is biologically critical for spliceosome function and RNA processing, RNU6-555P is a non-protein-coding pseudogene copy. Pseudogenes such as RNU6-555P commonly arise via gene duplication or retrotransposition and typically lack the function of their progenitor gene. In some cases, pseudogenes may have potential regulatory roles such as acting as decoys for microRNAs or modulating the expression of related genes, but no such role has been documented for RNU6-555P[4]. It is not a receptor, enzyme, transporter, or recognized therapeutic target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 555, pseudogene (RNU6-555P).